Aurora Cannabis Inc (NYSE:ACB)

7.51
BATS BZX Real-Time Price
As of 2:51pm ET
 -0.05 / -0.66%
Today’s Change
3.90
Today|||52-Week Range
12.53
+51.41%
Year-to-Date
Thinking about buying stock in Aurora Cannabis, Adobe, Axalta, Foresight Autonomous H...
9:37am / PR NewswirePRN - Paid Partner Content
4 of the 14 Most Widely Held Stocks on Investing App Robinhood Are Marijuana Stocks
Jun 16 / MotleyFool.comFOO - Paid Partner Content
Profit Projections Are Still Plunging for the 3 Most Popular Pot Stocks
6:42am / MotleyFool.comFOO - Paid Partner Content
A No-Nonsense Look at Aurora Cannabis' Bottom Line
Jun 15 / MotleyFool.comFOO - Paid Partner Content
Thinking about buying stock in Aurora Cannabis, Array Biopharma, Beyond Meat, Dare Bi...
Jun 17 / PR NewswirePRN - Paid Partner Content
Thinking about buying stock in Aurora Cannabis, Beyond Meat, Dryships, Lululemon Athl...
Jun 13 / PR NewswirePRN - Paid Partner Content
The Top 5 Marijuana Investing Mistakes to Avoid
Jun 17 / MotleyFool.comFOO - Paid Partner Content
Medical Products Industry Outlook: Growth Prospects Radiant
Jun 13 / Zacks.comZAK - Paid Partner Content
Better Buy: Aurora Cannabis vs. Gilead Sciences
Jun 16 / MotleyFool.comFOO - Paid Partner Content
10 Numbers to Focus On When Canopy Growth Reports Its Fourth-Quarter Results
Jun 12 / MotleyFool.comFOO - Paid Partner Content

Today’s Trading

Previous close7.56
Today’s open7.55
Day’s range7.49 - 7.64
Volume5,782,292
Average volume (3 months)23,938,899
Market cap$7.7B
Data as of 2:51pm ET, 06/19/2019

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+219.06%
P/E ratioNM
Price/Sales76.68
Price/Book3.62

Competitors

 Today’s
change
Today’s
% change
CRONCronos Group Inc+0.17+1.08%
ARGXargenx SE+2.02+1.51%
USNAUSANA Health Science...-2.76-3.71%
APHAAphria Inc-0.01-0.22%
Data as of 2:52pm ET, 06/19/2019

Financials

Next reporting dateSeptember 24, 2019
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$43.5M
Annual profit (last year)$56.6M
Net profit margin130.33%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Terry Booth
President &
Director
Steve Dobler
Corporate headquarters
Edmonton, Alberta

Forecasts